IRIS
MEROLA, Elettra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.841
AS - Asia 1.831
SA - Sud America 1.557
EU - Europa 421
AF - Africa 84
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 10.736
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.746
BR - Brasile 1.254
VN - Vietnam 636
SG - Singapore 445
HK - Hong Kong 241
CN - Cina 227
AR - Argentina 141
FR - Francia 94
DE - Germania 60
ID - Indonesia 59
EC - Ecuador 52
BD - Bangladesh 46
MX - Messico 45
RU - Federazione Russa 45
GB - Regno Unito 44
IN - India 41
IT - Italia 39
CA - Canada 29
PY - Paraguay 28
ZA - Sudafrica 27
CO - Colombia 25
IQ - Iraq 25
FI - Finlandia 21
ES - Italia 18
AT - Austria 17
UA - Ucraina 17
VE - Venezuela 15
CL - Cile 14
PK - Pakistan 14
PL - Polonia 13
MA - Marocco 12
SE - Svezia 12
JP - Giappone 11
NL - Olanda 11
PE - Perù 11
TR - Turchia 11
EG - Egitto 10
TN - Tunisia 10
UZ - Uzbekistan 10
KZ - Kazakistan 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
BO - Bolivia 8
SA - Arabia Saudita 8
DO - Repubblica Dominicana 7
JO - Giordania 6
KE - Kenya 6
NP - Nepal 6
OM - Oman 6
ET - Etiopia 5
IL - Israele 5
LT - Lituania 5
AZ - Azerbaigian 4
DZ - Algeria 4
BG - Bulgaria 3
IE - Irlanda 3
LB - Libano 3
RS - Serbia 3
SY - Repubblica araba siriana 3
BB - Barbados 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
JM - Giamaica 2
KW - Kuwait 2
NG - Nigeria 2
PA - Panama 2
PT - Portogallo 2
RO - Romania 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
ME - Montenegro 1
MT - Malta 1
MU - Mauritius 1
MZ - Mozambico 1
NI - Nicaragua 1
PR - Porto Rico 1
QA - Qatar 1
SD - Sudan 1
SN - Senegal 1
SV - El Salvador 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.736
Salva come PNG Salva come JPEG
Città #
Dallas 6.040
Ho Chi Minh City 261
Hong Kong 236
San Jose 206
Ashburn 163
Hanoi 138
Singapore 105
São Paulo 97
Beijing 83
Lauterbourg 80
Los Angeles 60
Rio de Janeiro 46
New York 31
Buenos Aires 27
Brasília 25
Haiphong 25
Orem 22
Curitiba 21
Campinas 18
Quito 18
Belo Horizonte 17
Munich 17
Chicago 16
Mexico City 16
Da Nang 15
Hải Dương 15
Montreal 15
Guayaquil 14
Santa Clara 14
Thái Bình 14
Caxias do Sul 13
Johannesburg 13
Warsaw 13
Biên Hòa 12
Fortaleza 12
Guarulhos 12
Ninh Bình 12
Porto Alegre 12
Uberlândia 12
Asunción 11
Buffalo 11
Düsseldorf 11
Frankfurt am Main 11
Goiânia 11
Helsinki 11
Juiz de Fora 11
Nuremberg 11
Atlanta 10
Baghdad 10
Bắc Giang 10
Niterói 10
Osasco 10
Rome 10
Stockholm 10
Tokyo 10
Turku 10
Chennai 9
Dhaka 9
Manchester 9
Piracicaba 9
Poplar 9
Ribeirão Preto 9
Salvador 9
Vienna 9
Amsterdam 8
Contagem 8
Jakarta 8
Phoenix 8
Thái Nguyên 8
Americana 7
Boston 7
Can Tho 7
Council Bluffs 7
Córdoba 7
Ha Long 7
Ipatinga 7
Lima 7
Manaus 7
Marília 7
Montevideo 7
Passo Fundo 7
Santa Maria 7
São Bernardo do Campo 7
São José 7
Tashkent 7
Alvorada 6
Amman 6
Cape Town 6
Ciudad del Este 6
Cotia 6
Denver 6
Duque de Caxias 6
Londrina 6
Maceió 6
Madrid 6
Montes Claros 6
New Delhi 6
Palmas 6
Phủ Lý 6
Recife 6
Totale 8.458
Salva come PNG Salva come JPEG
Nome #
Artificial intelligence in the diagnosis of gastro‐entero‐pancreatic neuroendocrine neoplasms: Potential benefits and current limitations 574
HETEROGENEITY OF TYPE 1 GASTRIC NEUROENDOCRINE NEOPLASMS 349
ACCURACY OF THE NOVEL TNM STAGING SYSTEM IN THE PROGNOSTIC STRATIFICATION OF PATIENTS WITH ADVANCED, STAGE IV DIGESTIVE ENDOCRINE TUMORS 343
Reassessment of Proliferative Activity at Disease Progression in Neuroendocrine Neoplasms 343
Curative Resection in Digestive Neuroendocrine Neoplasms: Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence 338
FOLFOX Chemotherapy: Efficacy and Tolerability in Advanced Digestive Neuroendocrine Neoplasms (NENs) 334
Clinical Usefulness of Functional Imaging Tests in the Follow-Up of Digestive Neuroendocrine Neoplasms 328
Peritoneal Carcinomatosis in Digestive Neuroendocrine Neoplasms: Complications and Response to Therapy 328
Contrast Enhanced Ultrasonography (CEUS) and Quantitative Perfusion Analysis in the Assessment of Neuroendocrine Liver Metastases 327
Functional imaging tests and CT scan: Detection of new metastases and clinical usefulness in digestive neuroendocrine neoplasms follow-up 326
Accuracy of the Novel TNM Staging System in the Prognostic Stratification of Patients With Advanced, Stage IV Digestive Endocrine Tumors 324
Evaluation of Multidisciplinary Tumor Board Decisions in the Management of Neuroendocrine Tumors: Impact of Expert Centers 319
Advanced Digestive Endocrine Tumors: Prognostic Factors Analysis and Patients Stratification According to Metastatic Status 314
Role of Somatostatin Receptors scintigraphy in neuroendocrine neoplasms follow-up 314
REASSESSMENT OF HISTOLOGICAL FEATURES AT DISEASE PROGRESSION DURING THE FOLLOW-UP OF NEUROENDOCRINE TUMOURS 310
Risk and Protective Factors for Midgut Carcinoid Tumours: Multicenter Case-Control Study of Prospectively Evaluated Patients 308
Risk and protective factors for midgut carcinoid tumors: Multicenter case-control study of prospectively evaluated patients 305
Histopathological Revision forGastroenteropancreatic NeuroendocrineNeoplasms in Expert Centers: Does It Make theDifference? 296
Functional imaging tests vs. computed tomography scan: detection of new metastases and clinical usefulness in digestive neuroendocrine neoplasms follow-up 291
Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate 255
Curative resection in digestive neuroendocrine neoplasms: Recurrence-free survival rate and definition of a risk score for recurrence 254
- Lineeguida AIOM-ITANET “Neoplasie Neuroendocrine gastroenteropancreatiche”; edizione 2015 183
Artificial Intelligence for Prognosis of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms 117
P53 and the malignant progression of Barrett's esophagus 97
ASO Visual Abstract: Radical Resection in Enteropancreatic Neuroendocrine Tumors-Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence 86
ASO Author Reflection: Risk of Recurrence After Radical Resection in Entero-Pancreatic Neuroendocrine Tumors 83
Appendiceal collision tumors: case reports, management and literature review 83
Cap-assisted EMR for large colorectal laterally spreading tumors: a cautionary tale from real-life experience 82
Clinical Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Diagnostic Algorithm of Advanced Entero-Pancreatic Neuroendocrine Neoplasms 82
Adverse events in gastrointestinal endoscopy: Validation of the AGREE classification in a real-life 5-year setting 81
Antiproliferative effect of somatostatin analogs in advanced gastro-entero-pancreatic neuroendocrine tumors: a systematic review and meta-analysis 80
Chromogranin A in the Follow-Up of Digestive Neuroendocrine Neoplasms: Is It a Useful Biomarker? 78
Acute leukaemia following low dose peptide receptor radionuclide therapy for an intestinal carcinoid 72
Cap-assisted endoscopic mucosal resection as a salvage technique for challenging colorectal laterally spreading tumors 72
Commentary: Predicting histologic grades for pancreatic neuroendocrine tumors by radiologic image-based artificial intelligence: a systematic review and meta-analysis 71
Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate 67
Advanced digestive neuroendocrine tumors: metastatic pattern is an independent factor affecting clinical outcome 66
Portosystemic encephalopathy in an 86-year-old patient : a clinical challenge 66
Functional Imaging in the Follow-Up of Enteropancreatic Neuroendocrine Tumors: Clinical Usefulness and Indications 64
Neuroendocrine tumors 63
Radical Resection in Entero-Pancreatic Neuroendocrine Tumors: Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence 62
Role of impaired epithelial barrier of esophageal body and of proximal reflux in the pathophysiology of non-erosive gastroesophageal reflux disease 62
Evaluation of multidisciplinary team decisions in neuroendocrine neoplasms: Impact of expert centres 61
Nasogastric or nasointestinal feeding in severe acute pancreatitis 61
Prevalence of gastrointestinal symptoms in coronavirus disease 2019: a meta-analysis 60
Two-devices-in-one-channel technique for precut sphincterotomy 60
Pre-Endoscopy real-time PCR testing for SARS-CoV2 does not reduce health care workers infection and is associated with a higher reduction of endoscopic activity in an outpatient setting 60
Radical intended surgery for highly selected stage IV neuroendocrine neoplasms G3 59
Therapeutic strategies for gastroenteropancreatic neuroendocrine neoplasms: State-of-the-art and future perspectives 59
Prevalence of liver injury in patients with coronavirus disease 2019 (COVID-19) : a systematic review and meta-analysis 59
Role of ACE1, ACE2, and CCR5-Δ32 Polymorphisms in the Transmission of SARS-CoV-2 to Intimate Contacts 58
Functional Imaging Tests versus Computed Tomography Scan: Detection of New Metastases and Clinical Usefulness in Digestive Neuroendocrine Neoplasms Follow-Up 57
Device-assisted enteroscopy: Are we ready to dismiss the spiral? 56
ENDOSCOPIC DIAGNOSIS OF NEUROENDOCRINE NEOPLASMS: A REAL-WORLD EXPERIENCE 55
Hepatitis C virus burden: Treating and educating people without prejudice 55
Stage IV gastro-entero-pancreatic neuroendocrine neoplasms. A risk score to predict clinical outcome 55
High rate of Ki-67 increase in entero-pancreatic NET relapses after surgery with curative intent 55
Efficacy and Toxicity of 5-Fluorouracil-Oxaliplatin in Gastroenteropancreatic Neuroendocrine Neoplasms 55
Peptide Receptor Radionuclide Therapy (PRRT): Innovations and Improvements 55
TYPE I GASTRIC CARCINOIDS: A PROSPECTIVE STUDY ON ENDOSCOPICMANAGEMENT AND RECURRENCE RATE 55
Sequential Therapies in Well-Differentiated Gastrointestinal Neuroendocrine Tumors G3 (NET G3): Platinum-Based vs. Platinum-Free Regimens 54
DIAGNOSTICS OF HEREDITARY COLORECTAL CANCER SYNDROMES: A REAL-WORLD EXPERIENCE 54
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet) 53
Molecular Pathology of Pancreatic Endocrine Tumors 52
Heart Team for Left Appendage Occlusion without the Use of Antithrombotic Therapy: The Epicardial Perspective 50
Treatment of Pancreatic Neuroendocrine Tumors 50
Role of intraoperative enteroscopy in the management of obscure gastrointestinal bleeding 49
Histopathological Revision for Gastroenteropancreatic Neuroendocrine Neoplasms in Expert Centers: Does It Make the Difference? 49
Probiotics and severe acute pancreatitis 49
Multicenter Analysis of Treatment Outcomes for Systemic Therapy in Well Differentiated Grade 3 Neuroendocrine Tumors (NET G3) 48
Digestive neuroendocrine neoplasms: A 2016 overview 47
Gastrointestinal tract injuries after thermal ablative therapies for hepatocellular carcinoma: A case report and review of the literature 47
Immunohistochemical evaluation of pRb2/p130, VEGF, EZH2, p53, p16, p21 waf-1, p27, and PCNA in Barrett's esophagus 45
Peritoneal Carcinomatosis in Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: Clinical Impact and Effectiveness of the Available Therapeutic Options 45
Optimal timing of endoscopy for acute upper gastrointestinal bleeding: a systematic review and meta-analysis 44
Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms? 44
Probiotics and severe acute pancreatitis. Addendum 43
Recurrence rates after piecemeal endoscopic mucosal resection of large colorectal laterally spreading tumors 42
Advances and future perspectives in the pharmacological treatment of Helicobacter pylori infection: Taking advantage from artificial intelligence 40
Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms 40
Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki-67 Is ≥10%? 39
PuraStat for gastrointestinal bleeding management: Effective approach for endoscopic prevention and rescue therapy 37
Resilience of the Gut Microbiome to Short Proton Pump Inhibitor Therapy With or Without High-Dosage L. reuteri in H. pylori-Infected Adults 26
Glucose-6-Phosphate Dehydrogenase Deficiency and Cardiovascular Risk in Familial Hypercholesterolemia: A Retrospective Cohort Study 23
Educational Materials for Helicobacter pylori Infection: A Comparative Evaluation of Large Language Models Versus Human Experts 20
Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET) 20
Bone metastases from neuroendocrine neoplasms: Resultsof an Italian nationwide survey of natural historyand management 19
Helicobacter pylori and Cancer: What’s the Link? 17
P0377 Dual-Energy and Photon-Counting Computed Tomography in Crohn’s Disease: Towards Quantitative Imaging Biomarkers. A Systematic Review 17
High-grade gastro-entero-pancreatic neuroendocrine neoplasms: An overlooked population in interventional clinical trials. A systematic review 15
Comment on: "Man Plus Machine: A Randomized Control Trial of Artificial Intelligence Including the Impact of Adjunctive Polyp Detection Techniques" 15
Predicting the Unpredictable: AI-Driven Prognosis in Pancreatic Neuroendocrine Neoplasms 10
Pancreatic Injuries: What Should Trauma Radiologists Know in 2026? 10
Persistence of the APOE ε4 Allele Among Sardinian Nonagenarians: Longitudinal Survival Evidence from a Blue Zone Cohort 4
Artificial Intelligence as a Safeguard for Clinical Scientific Integrity: A Human–AI Hybrid Model for Medical Peer Review 4
Interventional Clinical Trials in Metastatic Pulmonary Large-Cell Neuroendocrine Carcinoma: A Systematic Review of Prospective, Interventional Trials 4
Totale 10.857
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.420
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.420
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025944 0 0 0 0 0 0 0 0 0 749 97 98
2025/20269.913 325 3.316 3.510 1.584 245 219 303 147 164 100 0 0
Totale 10.857